Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-02

FDA Approved: CAPECITABINE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s generic capecitabine under an Abbreviated New Drug Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)

Snippet

ORIG AP for CAPECITABINE (CAPECITABINE)